Format

Send to

Choose Destination
Trends Pharmacol Sci. 2006 Dec;27(12):631-8. Epub 2006 Oct 19.

Angels and demons: neurotrophic factors and epilepsy.

Author information

1
Department of Clinical and Experimental Medicine, Section of Pharmacology, University of Ferrara, Ferrara 44100, Italy. michele.simonato@unife.it

Abstract

Several lines of evidence indicate that neurotrophic factors (NTFs) could be key causal mediators in the development of acquired epileptic syndromes. Yet the trophic properties of NTFs indicate that they might be used to treat epilepsy-associated damage. Accordingly, different NTFs, or even the same NTF, could produce functionally contrasting effects in the context of epilepsy. Recent experimental evidence begins to shed light on the mechanisms underlying these contrasting effects. Understanding these mechanisms will be instrumental for the development of effective therapies, which must be based on a careful consideration of the biological properties of NTFs. Here, we critically evaluate new information emerging in this area and discuss its implications for clinical treatment.

PMID:
17055067
DOI:
10.1016/j.tips.2006.10.002
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center